← Insider Monitor
BioStem Technologies, Inc. logo
BSEM

BioStem Technologies, Inc.

Nasdaq · Biological Products, (No Diagnostic Substances)

1
Insider trades
0
Congress trades

Company Overview

A concise company profile alongside the latest public filing activity.

BioStem Technologies develops and manufactures placental tissue-based allografts derived from the amniotic membrane and umbilical cord, which are used in wound care and other regenerative medicine applications. The company processes donated birth tissue into products marketed to healthcare providers for treating chronic wounds and other clinical conditions.

Industry
Biological Products, (No Diagnostic Substances)
Headquarters
Pompano Beach, FL
Exchange
Nasdaq

Company profile sourced from SEC filings.

Corporate Insider Trades

Open-market purchases and sales by directors, officers, and other company insiders.

InsiderTypeValueDate
Matuszewski JasonChief Executive OfficerSell$14KNov 17, 2026

Source: SEC EDGAR Form 4 filings

Congressional Trades

Recent disclosures by members of the U.S. House and Senate.

No recent congressional disclosures found for BSEM.

Source: Senate eFD and House Clerk STOCK Act disclosures

Get notable BSEM activity by email

Free alerts for the insider and congressional trades worth watching.

For informational purposes only, not investment advice. Filings can be delayed, corrected, or amended. Trading activity alone does not predict future performance.